TRIUMPH-1: #retatrutide topline data Phase 3, n=2,339, 80 wk, obesity without diabetes (efficacy estimand): 12 mg: -28.3% body weight (-31.9 kg) 9 mg: -25.9% | 4 mg: -19.0% | Placebo: -2.2% 30% weight loss: 45.3% vs 0.5% 104-wk extension (BMI 35, n=532), 12 mg MTD: -30.3% Cross-trial context (obesity, no diabetes): STEP-1 SEMA 2.4 mg, 68 wk: -14.9% SURMOUNT-1 TZP 15 mg, 72 wk: -20.9% TRIUMPH-1 RETA 12 mg, 80 wk: -28.3% But: Topline press release
Zinc protects sperm from being damaged by reactive oxygen species in assisted reproduction techniques
6509) was introduced in Congress, aiming to tighten federal oversight of compounding and outsourcing facilities
Potential Research Applications: Melanogenesis and eumelanin production studies UV-response and photoprotection research models Skin pigmentation and MC1R receptor signaling investigations Dermatological and pigmentation pathway research For laboratory research only
Accordingly, whether GLP-1RA can improve the prognosis of patients with colon cancer still needs to be further confirmed
Reconstitution done right: a mistake at the BAC water step on either peptide changes your dose by an order of magnitude